{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:56:23Z","timestamp":1761101783428,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.metabol.2006.10.014","type":"journal-article","created":{"date-parts":[[2007,2,9]],"date-time":"2007-02-09T07:05:52Z","timestamp":1171004752000},"page":"314-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia"],"prefix":"10.1016","volume":"56","author":[{"given":"Mirjam","family":"Langeveld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Scheij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Dubbelhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla E.M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans P.","family":"Sauerwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Simons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes M.F.G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2006.10.014_bib1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gauchers-disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2006.10.014_bib2","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity\u2014a novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2006.10.014_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2006.10.014_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1651-2227.2005.tb02110.x","article-title":"Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases","volume":"94","author":"Aerts","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.metabol.2006.10.014_bib5","first-page":"585","article-title":"Evaluation of three biochemical markers in the monitoring of Gaucher disease","volume":"28","author":"Vellodi","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.metabol.2006.10.014_bib6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2006.10.014_bib7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","article-title":"Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease","volume":"27","author":"Elstein","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.metabol.2006.10.014_bib8","doi-asserted-by":"crossref","first-page":"A13","DOI":"10.1259\/bjr.75.suppl_1.750013","article-title":"Imaging and quantifying skeletal involvement in Gaucher disease","volume":"75","author":"Maas","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1016\/j.metabol.2006.10.014_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1148\/radiology.185.3.1438773","article-title":"Quantitative imaging of Gaucher disease","volume":"185","author":"Rosenthal","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.metabol.2006.10.014_bib10","first-page":"2653","article-title":"Increased basal glucose-production in type-1 Gauchers-disease","volume":"80","author":"Corssmit","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.10.014_bib11","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/0026-0495(89)90165-0","article-title":"Resting energy-expenditure in Gauchers-disease type-1\u2014effect of Gauchers cell burden on energy-requirements","volume":"38","author":"Barton","year":"1989","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.metabol.2006.10.014_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0002-9343(97)00134-4","article-title":"Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease","volume":"103","author":"Hollak","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2006.10.014_bib13","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2006.10.014_bib14","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2006.10.014_bib15","doi-asserted-by":"crossref","first-page":"40352","DOI":"10.1074\/jbc.M300365200","article-title":"Impaired multimerization of human adiponectin mutants associated with diabetes\u2014molecular structure and multimer formation of adiponectin","volume":"278","author":"Waki","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2006.10.014_bib16","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin. Implications for metabolic regulation and bioactivity","volume":"278","author":"Pajvani","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2006.10.014_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(02)09335-2","article-title":"Adiponectin and development of type 2 diabetes in the Pima Indian population","volume":"360","author":"Lindsay","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2006.10.014_bib18","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.2337\/diacare.26.12.3315","article-title":"Plasma adiponectin and endogenous glucose production in humans","volume":"26","author":"Stefan","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2006.10.014_bib19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1148\/radiol.2292020296","article-title":"Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging\u2014initial experience","volume":"229","author":"Maas","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.metabol.2006.10.014_bib20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1006\/bcmd.2001.0474","article-title":"Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease","volume":"27","author":"Hollak","year":"2001","journal-title":"Blood Cells Mol Diseases"},{"key":"10.1016\/j.metabol.2006.10.014_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2006.10.014_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ajh.20011","article-title":"Rheological determinants in patients with Gaucher disease and internal inflammation","volume":"75","author":"Zimran","year":"2005","journal-title":"Am J Haematol"},{"key":"10.1016\/j.metabol.2006.10.014_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","article-title":"Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease","volume":"23","author":"Hollak","year":"1997","journal-title":"Blood Cells Mol Diseases"},{"key":"10.1016\/j.metabol.2006.10.014_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0925-4439(96)00056-7","article-title":"Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease","volume":"1317","author":"Michelakakis","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2006.10.014_bib25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bcmd.1997.0156","article-title":"Cytokine mRNA in Gaucher disease","volume":"23","author":"Lichtenstein","year":"1997","journal-title":"Blood Cells Mol Diseases"},{"key":"10.1016\/j.metabol.2006.10.014_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.metabol.2006.10.014_bib27","doi-asserted-by":"crossref","first-page":"E527","DOI":"10.1152\/ajpendo.00110.2003","article-title":"Regulation of adiponectin by adipose tissue\u2013derived cytokines: in vivo and in vitro investigations in humans","volume":"285","author":"Bruun","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.10.014_bib28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","article-title":"Adipose tissue, adipokines, and inflammation","volume":"115","author":"Fantuzzi","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.metabol.2006.10.014_bib29","doi-asserted-by":"crossref","first-page":"50810","DOI":"10.1074\/jbc.M309469200","article-title":"Role of disulfide bonds in Acrp30\/adiponectin structure and signaling specificity\u2014different oligomers activate different signal transduction pathways","volume":"278","author":"Tsao","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2006.10.014_bib30","first-page":"A198","article-title":"Changes of adiponectin oligomer composition by moderate weight reduction","volume":"48","author":"Bobbert","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2006.10.014_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/diabetes.52.2.239","article-title":"Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism","volume":"52","author":"Tschritter","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2006.10.014_bib32","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.10.014_bib33","doi-asserted-by":"crossref","DOI":"10.1042\/BJ20050460","article-title":"Defective insulin receptor activation and altered lipid rafts in Niemann-Pick type C disease hepatocytes","author":"Vainio","year":"2005","journal-title":"Biochem J"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049506003763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049506003763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:11:30Z","timestamp":1758424290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049506003763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0026049506003763"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2006.10.014","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2006.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}